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Abstract
Most of our knowledge regarding the process of protein import into mitochondria has come from research employing fungal systems. This
review outlines recent advances in our understanding of this process in mammalian cells. In particular, we focus on the characterisation of
cytosolic molecular chaperones that are involved in binding to mitochondrial-targeted preproteins, as well as the identification of both
conserved and novel subunits of the import machineries of the outer and inner mitochondrial membranes. We also discuss diseases associated
with defects in import and assembly of mitochondrial proteins and what is currently known about the regulation of import in mammals.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The mechanism of protein import into mitochondria is
highly conserved across phylogenetic boundaries. Many of
the molecular components, first identified in fungal species,
have now been found in animal species and the composition
of the core translocase components and major receptors is
essentially the same (Table 1). Additional components have
been implicated in the import process in mammalian cells,
but their function is still enigmatic. Nevertheless, a compar-
ison of molecular processes across phylogenetic boundaries
does assist in appraising various models that attempt to
explain the mechanistic steps in protein import.
In many animal cells, protein import, by necessity, has to
be separated from cell division, suggesting that mechanisms
for regulating the import process must exist. There is still
very little information on this aspect although pathways of
communication between mitochondria and the nucleus are
coming to light. Of particular importance is the emerging
realisation that mitochondrial dysfunction is at the centre of
many more medical conditions than previously anticipated.
These range from inborn errors of metabolism to later onset
neuromuscular disorders and a wide range of often unex-
pected phenotypes. Despite the fact that many of these are
due to nuclear mutations that affect the import, processing
and assembly of respiratory chain subunits of the inner
mitochondrial membrane, the molecular basis of most of
these conditions is yet to be described.
The increasing awareness of the importance of mitochon-
dria in proper cell function is exemplified by recent reviews
and editorials on the topic [1–3]. In this review we will
outline the state of knowledge of protein import into
mitochondria in mammalian cells and address some of the
issues enumerated above.
2. Cytosolic events in targeting
General pathways for the import of proteins into mito-
chondria are shown in Fig. 1. Most matrix-targeted proteins
are synthesised in the cytosol as precursors with N-terminal
targeting signals that can form positively charged amphi-
pathic a-helices [4–6]. These signals enable precursors to
be targeted to the mitochondrial surface prior to their import.
Early studies provided evidence for the existence of both co-
and posttranslational import into mitochondria [7,8]. The
discovery that ribosomes appear to bind specifically to
isolated mitochondria in a GTP-dependent manner and that
the binding characteristics are altered in the presence of
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precursor protein, lends further support to a co-translational
import model [9]. However, the establishment of an in vitro
import system employing fully translated precursors from
rabbit reticulocyte lysates added to isolated mitochondria,
has led to the conclusion that proteins can be imported in a
posttranslational fashion. Since a prerequisite for membrane
translocation is that precursors are in an unfolded or
extended conformation, it has been reasoned that cytosolic
factors are involved in chaperoning precursors from their
site of synthesis to the mitochondrial surface. Subsequently,
a number of cytosolic factors have been isolated on the basis
of their association with precursor proteins.
Since the typical in vitro import assay utilizes a mamma-
lian translation system, even when fungal mitochondria are
used, virtually all cytosolic factors implicated in the import
process have been isolated from mammalian sources. Some
of these assist in maintaining import competence and others
may interact directly with the presequence and thereby assist
protein targeting to receptor components on the outer
membrane of mitochondria. The constitutively expressed
cytosolic isoform of Hsp70 (Hsc70) has been shown to
Table 1
Fungal and mammalian components involved in protein import into
mitochondria
Fungi Mammals
Cytosol Hsp70 (ssa1/2p) Hsc70
Cytosolic DnaJ (Ydj1p) dj2 (HSDJ/hdj-2), dj3
MSF
PBF
Targeting factor
Outer membrane Tom70, Tom71 Tom70
Tom40 Tom40
Tom34
Tom37
Tom22 Tom22
Tom20 Tom20
Tom7 Tom7
Tom6 OM10a
Tom5 OM7.5a
OM5a
OM37
Metaxin 1/2
Intermembrane space Tim13 Tim13
Tim10 Tim10ab
Tim10bb
Tim9 Tim9
Tim8 Tim8a (DDP1)
Tim8b (DDP2)
Inner membrane Tim23 Tim23
Tim17 Tim17a
Tim17b
Tim44 Tim44
Tim54
Tim22 Tim22
Tim18
Tim12
Matrix mtHsp70 (Ssc1p) mtHsp70
Mge1 hTid (mtDnaJ)
Mdj1 mtGrpE
MPP MPP
MIP MIP
Cpn60 Cpn60
Cpn10 Cpn10
a Primary sequence data of these proteins has not been published but
they may be homologues to the fungal small Tom proteins.
b Tom10a or Tim10b may be functionally homologous to fungal
Tim12.
Fig. 1. Components of the (A) fungal and (B) mammalian mitochondrial
protein import apparatus. The general protein import pathways for matrix-
targeted precursor proteins containing N-terminal targeting signals (left)
and those targeted to the inner membrane (right) are shown. Subunits that
are unique to either system are shaded grey. Note that homologues may
exist but they have yet to be identified.
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maintain mitochondrial precursor proteins in an import
competent state [10]. When Hsc70 was first immunode-
pleted from the reticulocyte lysate mix that contained newly
synthesised precursor proteins, protein import was disrupted
[11]. Only when Hsc70 was present during translation did
the precursor protein remain competent for import into
mitochondria since addition of purified Hsc70 to the import
reaction after precursor synthesis did not restore the import
defect [11]. The presence of N-terminal presequences in
newly synthesised precursor proteins may prevent their
folding and therefore lead to a prolonged association with
Hsc70. For example, the mitochondrial isoform of aspartate
amino transferase stably binds Hsc70, whereas the cytosolic
isoform does not [12]. A small fraction of Hsc70 is
associated tightly with the mitochondrial outer membrane
[13], suggesting that a docking mechanism for delivery of
precursors to the mitochondrial receptors may exist.
Hsc70 usually performs its chaperone function in asso-
ciation with the co-chaperones DnaJ and GrpE. While there
is no information to support a role of the cytosolic GrpE
homologue Bag-1 [14] in protein import, two of the three
known mammalian cytosolic isoforms of DnaJ, dj2 and dj3
are required for import of some precursor proteins [15–17].
Based on reticulocyte depletion studies, dj2 and dj3 were
shown to be required for import of some precursor proteins,
whereas another DnaJ isoform, dj1, was not [16,17]. The
role of Hsc70 and dj2 function in the import process is
somewhat removed from their usual role of assisting in the
folding of newly synthesised proteins. Instead, their inter-
action with precursors seems to be retained until their
delivery to the mitochondrial receptors [18]. The way in
which they achieve this is not known, but what distinguishes
mitochondrial precursor proteins from other proteins is the
presence of targeting signals and their binding-factors in the
cytosol. While Hsc70 plays a role in protein import, it does
not appear to be essential for the delivery of all precursors to
the mitochondria [18].
A number of other cytosolic factors implicated to be
involved in targeting have been reported and include:
targeting factor [19], a 28-kDa protein affinity purified
using a signal peptide; presequence binding factor (PBF;
[20,21]), a 50-kDa protein purified on affinity resin con-
taining recombinant precursors of ornithine transcarbamy-
lase (pOTC); and mitochondrial import stimulation factor
(MSF), a heterodimer of 66 kDa, isolated from rat liver [22].
Aside from the initial reports almost a decade ago, no
further characterisation of targeting factor or PBF has been
reported. MSF was isolated on the basis of its stimulation of
pre-adrenodoxin import [22]. It has been shown to require
ATP for its function and it is also sensitive to treatment with
N-ethylmaleimide [23,24]. Not all precursor proteins require
MSF for import [25] and this factor appears to have no
functional homologue in lower eukaryotes. Nevertheless,
based on reconstitution experiments with yeast mitochon-
dria and outer membrane preparations, a model has been
proposed whereby MSF delivers precursor proteins to the
outer membrane receptor, Tom70. The precursor proteins
can then be passed to Tom20 and Tom22 before trans-
location across the outer membrane [26,27]. In experiments
with the soluble domains of yeast Tom receptors, it has been
shown that MSF forms a complex with the cytosolic domain
of Tom70 in the presence of precursor protein, with release
of MSF and subsequent precursor transfer to the cytosolic
domain of Tom20 upon ATP hydrolysis [27].
3. The mammalian TOM machinery
Mammalian homologues of fungal translocase compo-
nents of the outer mitochondrial membrane (TOM) that
have been identified to date include the receptors Tom20,
Tom22, Tom70 and the channel protein Tom40 (Fig. 1).
Additionally, co-immunoprecipitation experiments using
Tom40 antibodies have identified a number of small
molecular weight proteins of 10, 7.5 and 5 kDa that may
represent homologues of Tom7, Tom6 and Tom5. A
human Tom7 has been identified and like its fungal
counterparts, is found in association with the core Tom
complex (Johnston, Hoogenraad and Ryan, in preparation).
The first mammalian Tom subunit to be identified was
Tom20 [28–30]. Although showing more than 50%
sequence identity with fungal Tom20, it is a somewhat
smaller protein being only 16.3 kDa in size. It is N-
terminally anchored by a hydrophobic transmembrane
domain and has a 13 kDa cytosolic receptor domain
[30]. Human Tom20 was shown to be able complement
respiratory defects of yeast cells lacking Tom20 and could
interact with other Tom subunits in yeast [28,29]. Further-
more, antibodies against the soluble domain of human
Tom20 were able to inhibit mitochondrial protein import
in vitro [29,30]. Addition of the purified soluble receptor
domain of mammalian Tom20 to in vitro import assays
was also shown to competitively inhibit the import of a
range of mitochondrial-targeted precursor proteins [31,32].
The ability of the cytosolic domain to fold in association
with a mitochondrial signal peptide allowed its structure to
be determined by NMR [6]. This structure revealed that an
interaction occurred between the hydrophobic face of the
amphipathic signal peptide and a cleft formed by stacking
of three a-helices in Tom20. The cleft also includes part of
the single tetratricopeptide repeat (TPR) domain of the
receptor [6]. TPR domains have been found in a number of
TOM subunits and these domains have been implicated to
be involved in mediating protein–protein interactions [33].
The association of the hydrophobic face of the prese-
quence with Tom20 leaves the basic face to interact with
some other, yet to be identified component of the import
machinery. Potential candidates for interaction may include
the Tom22 receptor, or cytosolic chaperones that may dock
onto Tom20 for precursor delivery. Whereas Tom20 has a
highly acidic carboxy-terminus (EDDVE) that protrudes
towards the cytosol, this region was not in contact with the
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signal peptide in the 3-D structure [6]. Interestingly,
complementation studies with mutant forms of human
Tom20 in yeast suggested that neither the TPR domain
nor the carboxy-terminal acidic domain were essential for
the activity of Tom20 [34]. It is of interest to note that
yeast Tom20 also has this acidic domain whereas Tom20
from Neurospora crassa does not.
In a surprising finding, it was shown that overexpres-
sion of human Tom20 in mammalian cells causes a major
disruption in the morphology and distribution of mitochon-
dria [35], resulting in the perinuclear aggregation of
mitochondria. This suggests that Tom20 may be implicated
in the association of mitochondria with the cytoskeleton of
mammalian cells and that a disturbance in the stoichiom-
etry of the Tom components disrupts this association. This
observation supports previous findings that Tom20-defi-
cient N. crassa cells contain mitochondria that have
reduced numbers of cristae [36], also implicating a role
for Tom20 in the maintenance of fungal mitochondrial
morphology. Overexpression of the receptor also produced
a dominant negative inhibitory effect on import of the
mitochondrial matrix-targeted precursor protein, pOTC.
Deletion analysis of hTom20 [37] showed that a linker
region between the transmembrane domain and a gluta-
mine rich domain [38] is essential for the dominant
negative effect.
Mammalian homologues of the Tom70 [39] and
Tom22 [40] receptors have also been identified. As in
fungi, Tom70 does not remain associated with the core
Tom complex following separation by native PAGE,
whereas Tom22 is tightly associated with Tom40 in a
complex of between 380 and 400 kDa [41]. Although
mammalian Tom20 is also loosely associated with the
Tom complex, it nevertheless associates with Tom22 since
the two Tom receptors can be co-immunoprecipitated with
antibodies specific for either receptor [40,41]. Both fungal
and mammalian counterparts of Tom22 have a carboxy-
terminal intermembrane space domain and an N-terminal
cytosolic receptor domain. Mammalian Tom22 is substan-
tially smaller than its fungal homologue, having a size of
15.5 kDa. However, like fungal Tom22, it has a strongly
acidic N-terminal domain, which interacts with mitochon-
drial precursor proteins [40]. On the other hand, the
intermembrane space domain of mammalian Tom22
shows little sequence similarity to the fungal ortholog,
particularly in as far as it lacks the acidic character of the
fungal receptor. This raises questions about the ‘‘acid-
chain’’ hypothesis, which proposes a pathway involving
electrostatic interaction of increasing affinity between the
basic targeting signals of precursors, and acidic domains
on import subunits on either side of the outer membrane.
Such conclusions were based on studies with soluble
domains of fungal receptors, particularly the cytosolic
and intermembrane space acid domains of Tom22 [42].
This has led to a modification of the ‘‘acid-chain’’
hypothesis to a ‘‘binding chain’’ hypothesis, which pro-
poses that there is a sequence of increasing affinities for
interactive sites on translocation components with which
precursor proteins interact during import [43]. This mod-
ification also can account for the translocation of precur-
sor proteins that lack typical N-terminal targeting signals,
such as many intermembrane space and some inner-
membrane destined proteins.
Rat [41] and human [44] Tom40 homologues have also
been identified as 38-kDa outer membrane proteins with
structural similarity to fungal Tom40. Rat Tom40 was found
to be buried in the outer membrane and only accessible to
protease digestion from the intermembrane space side.
Furthermore, a precursor protein containing a folded cyto-
solic domain arrested at mitochondrial translocation sites
was found to be associated with rat Tom40 [41].
A number of additional proteins associated with the
mitochondrial outer membrane have also been implicated
in protein import. Metaxin is a C-terminally anchored
protein that was proposed to be a component of the
translocation machinery in mammalian cells based on the
ability of antibodies against metaxin to inhibit import of
preadrenodoxin [45]. The metaxin gene is located between
the glucocerebrosidase and thrombospondin 3 genes in
mice and shown to be required for embryonic development
[46]. Metaxin shows some homology to yeast Tom37.
Tom37 was reported to associate with Tom70 and to
facilitate mitochondrial import [47]. Although overexpres-
sion of metaxin in mammalian cells results in a mild
inhibition of mitochondrial protein import, it is not asso-
ciated with subunits of the TOM complex [41,44]. A
cytosolic isoform of metaxin, termed metaxin 2, was later
identified and found to interact with metaxin 1 at the
surface of the mitochondrial outer membrane [48]. Anti-
bodies against metaxin 2 did not prevent the import of pre-
adrenodoxin into mitochondria [48]. More recently, Meta-
xin 1 has been reported to be required for tumor necrosis
factor-induced necrotic and apoptotic cell death [49]. The
relationship between apoptotic cell death and mitochon-
drial protein import, if any, is yet to be investigated. OM37
is a 37-kDa mitochondrial outer membrane protein identi-
fied from mammalian cells whose antibodies were also
found to inhibit protein import [25]. It apparently has no
fungal homologue and is proposed to function as the
receptor for the MSF-precursor protein complex [25].
OM37 was not co-immunoprecipitated with Tom40 or
Tom20 antibodies [41]. Human Tom34, a TPR containing
protein, was found to have sequence homology with
Tom70 [50]. Specific antibodies, as well as the soluble
cytosolic domain of Tom34, were shown to inhibit the
import of a subset of mitochondrial precursors [51].
Tom34 is found partially in the cytosol and partially
associated with the mitochondrial outer membrane as a
peripheral membrane protein [51].
The function and contribution of the mammalian proteins
described above in the process of mitochondrial protein
import remains unresolved. It may be that these proteins are
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responsible for the stimulation of import of only a minor
number of precursor proteins. Interestingly, human Tom34
was identified in a yeast 2-hybrid screen, as a protein that
binds to the carboxy-terminal fragment of Hsp90, the
interconnection being through the Tom34 TPR domain [33].
4. The mammalian TIM machinery
Whereas the outer mitochondrial membrane contains a
single TOM preprotein translocase, the inner membrane
contains two distinct TIM translocases, including a suite
of small TIM components in the intermembrane space
(reviewed elsewhere in this issue). A number of mammalian
homologues of fungal TIM components have been identi-
fied and at least one of these proteins has been of particular
interest since mutations in its gene have been implicated in
causing a neurodegenerative disorder.
The TIM23 complex containing the subunits Tim23,
Tim17 and Tim44 is involved in the import of those
precursor proteins containing typical N-terminal targeting
signals [43]. These include all matrix targeted precursors as
well as some precursors that additionally contain hydro-
phobic stop-transfer signals, which lead to their arrest in the
inner membrane. Homologous subunits of the yeast TIM23
complex have been found in mammals. However, while
single genes encode human Tim23 and Tim44, two genes
encoding Tim17 have been found [52,53]. Both isoforms of
Tim17 seem to be ubiquitously expressed and they each
form separate complexes with Tim23—although the reason
for this is not known [53]. Mammalian Tim44 was first
identified by its fivefold increase in expression in diabetic
newborn mice [54]. Interestingly, overexpression of this
protein led to some mitochondria displaying paracrystalline
cristae. The upregulation of Tim44 (and perhaps other TIM
and TOM components), as a response to elevated glucose
concentrations arising from diabetes, may lead to the more
efficient import of nuclear-encoded mitochondrial enzymes
involved in oxidative phosphorylation. While fungal Tim44
is tightly associated with the matrix-face of the inner
membrane [55], mammalian Tim44 is largely found in the
soluble matrix fraction [53,56]. Furthermore, an association
of Tim44 with Tim23 and Tim17 has not been observed
[53,56], although rat Tim44 has been found to associate
with matrix Hsp70 in the absence of ATP [56]. In fungi, it
has been proposed that Tim44 functions as an anchor for
matrix Hsp70, so that this chaperone can bind and assist in
the translocation of precursor proteins. ATP hydrolysis is
thought to result in structural rearrangements of Hsp70,
leading to the generation of force and pulling of precursors
into the matrix [43]. A different model suggests that rather
than pulling, Hsp70 binding is more passive and prevents
the retrograde movement of precursors [57]. Since mamma-
lian Tim44 is largely found in the matrix fraction of
mitochondria, it suggests that mtHsp70 in this system may
not be able to perform a pulling function. Further character-
isation of these components in mammalian mitochondria is
necessary to clarify their roles in protein translocation.
The TIM22 complex in yeast is involved in the import of
integral inner membrane proteins such as metabolite carrier
precursors. The complex consists of the integral membrane
subunits Tim22, Tim54 and Tim18, along with a number of
small Tims that represent a novel family of zinc finger
proteins that contain a conserved Cys4 zinc finger motif
[58]. The small Tim proteins most likely serve as molecular
chaperones in targeting precursor proteins from the Tom
complex across the intermembrane space to the Tim22
insertion complex. They may also facilitate the forward
movement of a subset of precursor proteins across the Tom
machinery. Mammalian homologues of a number of these
Tim proteins have been found [59,60]. These include human
Tim22 as well as numerous small Tim proteins—Tim8a
(also known as DDP1), Tim8b (DDP2), Tim9, Tim10a,
Tim10b and Tim13. Recent studies indicate that these small
Tim proteins perform similar roles to that of their yeast
counterparts. Human Tim13 and Tim8 isoforms seem to
bind to translocation intermediates of the precursor to
Tim23 in the intermembrane space and assist in its move-
ment to the inner membrane [61]. Presumably, these Tim
proteins are involved in the import, not just of Tim23, but a
number of different inner membrane targeted precursors that
exhibit extensive hydrophobic regions. The finding that
mutations in the gene encoding Tim8a (DDP1) lead to a
neurodegenerative disorder termed Mohr–Tranebjaerg syn-
drome (or deafness dystonia), has led to conclusions that
import defects are somehow responsible for causing this
disease [59].
5. Processing, folding and assembly
A number of matrix factors have been identified for
processing, folding and assembly of proteins imported into
mitochondria. The mitochondrial isoform of Hsp70 func-
tions in conjunction with Tim44 and mitochondrial GrpE as
a translocation motor (see other contributions in this series).
Mammalian homologues of these well-characterized fungal
proteins have been identified [53,56,62,63]. Hsp70 has an
additional role in protein folding, where it cooperates with
mtGrpE and mtDnaJ (or Tid), a recently identified mito-
chondrial co-chaperone [64]. Once in the matrix, mitochon-
drial targeting signals (or presequences) are usually
processed by certain processing peptidases. These proteases
were first identified in mammalian tissues [65,66]. Mito-
chondrial processing peptidase (MPP) is a metalloprotease
that typically requires arginine residues at  2 or  3 from
the cleavage point. Proline and glycine are also required for
specificity [67,68]. Some precursor proteins such as pOTC
are processed in two steps. The first cleavage is catalyzed by
MPP and the second is catalyzed by the mitochondrial
intermediate peptidase (MIP) [69], a zinc metalloprotease
that recognises amino-terminal octapeptides as a recognition
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sequence [70]. Other matrix precursor proteins are not
proteolytically processed, such as mammalian rhodanese
and Chaperonin 10 [71].
Following processing, mitochondrial matrix proteins are
folded, often with the assistance of molecular chaperones
such as the Hsp70 or the chaperonin machineries [72]. Each
of these has homologues in eubacteria, such as E. coli, and
essentially all of the counterparts of bacterial chaperones
have now been identified in fungal and animal species. The
mitochondrial GroEL homologue, termed Chaperonin 60
(Cpn60) or Hsp60, was first isolated from human cells [73]
while the GroES homologue, Cpn10, was first purified from
rat liver [74]. The mammalian genes encoding these two
chaperonins were found to be joined by a single bi-direc-
tional promoter [75]. Although most of our understanding of
chaperone-mediated protein folding has arisen from the
study of bacterial systems, mitochondrial substrates for
yeast Cpn60 and Cpn10 have recently been examined
[76]. Like bacterial GroEL, yeast Cpn60 forms a tetradode-
cameric structure consisting of two toroidal rings of seven
subunits, capped at either end by Cpn10 heptamers. How-
ever, while a doubled-ringed structure has been described
[77], the minimal functional unit for mammalian Cpn60
appears to be a single heptameric ring [78]. Little informa-
tion is available so far on the contribution made by mam-
malian mitochondrial chaperonins in the folding of newly
imported matrix proteins.
6. Defects in import and assembly
Because of the central role played by mitochondria in the
generation of ATP via oxidative phosphorylation, many
mitochondrial diseases are characterized by symptoms that
express themselves in tissues that are highly dependent on
the availability of ATP. Thus, neurological disorders are
common outcomes of mitochondrial disorders as well as
myopathies and defects arising from deficiencies in secre-
tory tissues such as the pancreas. Although several hundred
mutations in mitochondrial resident DNA (mtDNA) have
been described since the first report in 1988 [79], relatively
few nuclear gene defects causing mitochondrial disease
have been reported. It is interesting to note that a number
of diseases not thought to be ‘‘mitochondrial’’ are now
known to be due to mutations in nuclear genes encoding
mitochondrial proteins. These include Friedrich’s ataxia,
neuroblastic anemia, Wilson’s disease (all diseases in metal
iron transport), hereditary spastic paraplegia, deafness dys-
tonia (Mohr–Tranebjaerg) syndrome and optic atrophy
[1,59,80,81].
It is also notable that most of the gene defects identified
to date do not encode respiratory chain subunits, but rather
genes affecting protein import, subunit processing and
assembly of complexes. For example, the SURF1 gene
has been implicated in the assembly of Complex IV (cyto-
chrome c oxidase), and defects in this gene lead to Leigh’s
syndrome [82,83]. Hereditary spastic paraplegia was found
to be due to a defect in the SPG7 (paraplegin) gene,
encoding a homologue of the yeast AAA protease/chaper-
one required for the assembly of the ATP synthase complex
(complex V); [84]. Deafness dystonia syndrome is caused
by mutations in DDP1 [59], an intermembrane space small
Tim protein homologous to yeast Tim8 (see above).
It is of interest to note that so far no defects arising from
mutations in TOM components have been described. Given
that protein import into mitochondria is a general process
essential for cell viability, any mutations in genes encoding
subunits of the import machinery would probably result in
premature termination, most likely at the embryonic stage of
development. A number of diseases have been described,
however, that are a result of more specific import defects
due to mutations in the presequences of mitochondrial
matrix proteins. These include ornithine transcarbamylase
[85]; methylmalonyl-CoA mutase [86]; and the El a subunit
of pyruvate dehydrogenase [87]. Mutations affecting pro-
teolytic processing after import have also been described
[88,89]. In addition, a mutation in peroxisomal L-alanine:-
glyoxylate aminotransferase has also been reported that
results in the creation of a cryptic mitochondrial targeting
signal leading to mistargeting of this protein to mitochondria
[90]. Disease states have also been attributed to the
decreased expression of matrix-located Cpn60 [91].
7. Regulation of import and mitochondrial–nuclear
communications
Since most of the genes that regulate the function of
mitochondria are located in the nucleus, it is axiomatic that
there must be effective communication between mitochon-
dria and the nucleus. For example a classic outcome of
defects in oxidative phosphorylation due to mutations in
mtDNA is a massive proliferation of mitochondria [1].
Thus, genes for mitochondrial biogenesis must be upregu-
lated and mitochondrial biogenesis must be under some
form of control, a process that presumably requires inter-
organellar communication [92]. Evidence for such commu-
nication comes from the substantial changes in gene expres-
sion profiles in yeast that have had their mtDNA removed
[93]. In mammalian cells, a pathway of signalling has been
reported, based on release of calcium by mitochondria via a
c1-Jun N-terminal kinase pathway [94]. This signalling
occurs in response to both genetic stress caused by the
partial deletion of mtDNA and metabolic stress caused by
mitochondrial oxidative phosphorylation inhibitors. This
pathway is also implicated in tumour progression and
metastasis [95].
Little is known about the regulation and expression of the
nuclear genes encoding subunits in the mitochondrial import
machinery. While expression analysis of a number of TIM
genes indicates that they are constitutively and ubiquitously
expressed [53], it seems that expression of the gene encod-
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ing human Tom70 is additionally regulated by thyroid
hormone [39]. Thyroid hormone is an important regulator
of growth and development in mammals and the increased
synthesis of import components and the resulting increased
import may increase oxidative metabolism in cells. Interest-
ingly, thyroid hormone treatment has been shown to result
in the increase in both mitochondrial volume and mitochon-
drial cristae in cardiac cells while hyperthyroidism leads to
increased concentrations of mitochondrial protein content
[96,97]. Analysis of mitochondria from cells treated with
thyroid hormone showed an increase in the amount of
Tom20 and mtHsp70 along with an increased rate of protein
import into the matrix [98]. From this example, it appears
that the cell may be able to increase the demands it places on
mitochondria by regulating the expression of components of
the mitochondrial import apparatus in order to facilitate the
metabolic needs of the cell.
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